{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T20:48:17Z","timestamp":1794516497942,"version":"4.9.1"},"reference-count":40,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: This study aimed to evaluate the treatment outcomes of adults with pulmonary drug-susceptible tuberculosis (DS-TB) in Lithuania over 22 years, and to examine associations between treatment outcomes, various risk factors, and temporal trends. Materials and Methods: A retrospective cohort analysis was conducted using data from the National Tuberculosis Information System from 2000 to 2021. A total of 18,697 adult patients with DS-TB were included. Patients were grouped into three time periods: Period I (2000\u20132007), Period II (2008\u20132015), and Period III (2016\u20132021). Treatment outcomes were categorized as successful (treatment completed with recovery) or unsuccessful (patients who encountered treatment failure, died during treatment, or converted to drug-resistant tuberculosis). Associations with individual risk factors, including smoking, alcohol use, comorbidities, and sociodemographic variables, were analyzed. Results: Treatment success rates improved steadily across the study periods: 82.3% in Period I, 84.4% in Period II, and 87.6% in Period III. Mortality rates declined over time but remained substantial: 17.1%, 15.2%, and 12.0% in Periods I, II, and III, respectively. Non-lethal treatment failures decreased slightly (0.6%, 0.4%, and 0.4%). Multivariate analysis identified significant associations between treatment failure and multiple risk factors, including low BMI, male gender, unemployment, homelessness, smoking, alcohol and substance use, and comorbid conditions such as cancer, cardiovascular disease, chronic lung disease, diabetes mellitus, HIV, and renal failure. Conclusions: Treatment outcomes for DS-TB in Lithuania have improved over the past two decades; however, certain modifiable risk factors\u2014such as low BMI, homelessness, substance use, and comorbidities\u2014remain strongly linked to treatment failure. To further improve outcomes, targeted interventions such as nutritional support, housing programs, and integrated addiction services should be prioritized for high-risk groups within national TB control efforts.<\/jats:p>","DOI":"10.3390\/medicina61101805","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:56:29Z","timestamp":1759996589000},"page":"1805","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk Factors for Treatment Failure of Drug-Susceptible Pulmonary Tuberculosis in Lithuania over 22 Years"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7815-1858","authenticated-orcid":false,"given":"Karolina","family":"K\u0117velaitien\u0117","sequence":"first","affiliation":[{"name":"Institute of Clinical Medicine, Clinic of Chest Diseases, Immunology and Allergology, Vilnius University Faculty of Medicine, LT-03101 Vilnius, Lithuania"},{"name":"Centre of Pulmonology and Allergology, Vilnius University Hospital Santaros Klinikos, LT-08661 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7571-4989","authenticated-orcid":false,"given":"Roma","family":"Puronait\u0117","sequence":"additional","affiliation":[{"name":"Center of Informatics and Development, Vilnius University Hospital Santaros Klinikos, LT-08406 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerija Edita","family":"Davidavi\u010dien\u0117","sequence":"additional","affiliation":[{"name":"Programs and Tuberculosis State Information System Department, Vilnius University Hospital Santaros Klinikos, LT-08661 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birut\u0117","family":"Nak\u010derien\u0117","sequence":"additional","affiliation":[{"name":"Programs and Tuberculosis State Information System Department, Vilnius University Hospital Santaros Klinikos, LT-08661 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2726-1991","authenticated-orcid":false,"given":"Edvardas","family":"Danila","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, Clinic of Chest Diseases, Immunology and Allergology, Vilnius University Faculty of Medicine, LT-03101 Vilnius, Lithuania"},{"name":"Centre of Pulmonology and Allergology, Vilnius University Hospital Santaros Klinikos, LT-08661 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(19)30308-3","article-title":"Tuberculosis","volume":"393","author":"Furin","year":"2019","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3329\/jhpn.v28i2.4879","article-title":"Tuberculosis: A Global Health Problem","volume":"28","author":"Zaman","year":"2010","journal-title":"J. Health Popul. Nutr."},{"key":"ref_3","unstructured":"World Health Organization (2013). Definitions and Reporting Framework for Tuberculosis, World Health Organization. revision (updated December 2014 and January 2020)."},{"key":"ref_4","unstructured":"World Health Organization (WHO) (2024). Global Tuberculosis Report 2024, World Health Organization. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/379339\/9789240101531-eng.pdf?sequence=1."},{"key":"ref_5","unstructured":"World Health Organization (2025, July 17). Tuberculosis [Internet]. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis."},{"key":"ref_6","unstructured":"World Health Organization (2015). The End TB Strategy [Internet], World Health Organization. Available online: https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/the-end-tb-strategy."},{"key":"ref_7","unstructured":"European Centre for Disease Prevention and Control, and World Health Organization Regional Office for Europe (2025). Tuberculosis Surveillance and Monitoring in Europe 2025\u20142023 Data, ECDC\/WHO Regional Office for Europe. Available online: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/TB-2025-Surveillance-report.pdf."},{"key":"ref_8","unstructured":"European Centre for Disease Prevention and Control, and World Health Organization Regional Office for Europe (2023). Tuberculosis Surveillance and Monitoring in Europe 2023\u20142021 Data, ECDC\/WHO Regional Office for Europe. Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/tuberculosis-surveillance-and-monitoring-europe-2023-2021-data."},{"key":"ref_9","unstructured":"European Centre for Disease Prevention and Control (2024). Tuberculosis. Annual Epidemiological Report for 2022, ECDC. Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/tuberculosis-annual-epidemiological-report-2022."},{"key":"ref_10","unstructured":"The State Information System of Tuberculosis. Tuberculosis treatment outcomes\u20142025 data on file."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2305930","DOI":"10.1080\/16549716.2024.2305930","article-title":"Low Body Mass Index as a Predictor of Sputum Culture Conversion and Treatment Outcomes among Patients Receiving Treatment for Multidrug-Resistant Tuberculosis in Lesotho","volume":"17","author":"Lawrence","year":"2024","journal-title":"Glob. Health Action"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"857","DOI":"10.5588\/ijtld.15.0936","article-title":"Protein-Calorie Malnutrition, Micronutrient Supplements, and Tuberculosis","volume":"20","author":"Koethe","year":"2016","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"K\u00f6ltringer, F.A., Annerstedt, K.S., Boccia, D., Carter, D.J., and Rudgard, W.E. (2023). The Social Determinants of National Tuberculosis Incidence Rates in 116 Countries: A Longitudinal Ecological Study between 2005\u20132015. BMC Public Health, 23.","DOI":"10.1186\/s12889-023-15213-w"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2147\/PROM.S463396","article-title":"Prevalence, Clinical Characteristics and Determinants of Unsuccessful Treatment Outcomes Among Pulmonary Tuberculosis Patients: A 5-Year Registry-Based Retrospective Cohort Study","volume":"15","author":"AlOsaimi","year":"2024","journal-title":"Patient Relat. Outcome Meas."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Matulyte, E., Davidaviciene, E., Kancauskiene, Z., Diktanas, S., Kausas, A., Velyvyte, D., Urboniene, J., Lipnickiene, V., Laurencikaite, M., and Danila, E. (2023). The Socio-Demographic, Clinical Characteristics and Outcomes of Tuberculosis among HIV-Infected Adults in Lithuania: A Thirteen-Year Analysis. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0282046"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"6661","DOI":"10.2147\/IJGM.S367090","article-title":"Clinical Characteristics and Outcomes in Chronic Kidney Disease Patients with Tuberculosis in China: A Retrospective Cohort Study","volume":"15","author":"Xiao","year":"2022","journal-title":"Int. J. Gen. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"783","DOI":"10.5588\/ijtld.18.0433","article-title":"The Effects of Diabetes on Tuberculosis Treatment Outcomes: An Updated Systematic Review and Meta-Analysis","volume":"23","author":"Huangfu","year":"2019","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Gautam, S., Shrestha, N., Mahato, S., Nguyen, T.P.A., Mishra, S.R., and Berg-Beckhoff, G. (2021). Diabetes among Tuberculosis Patients and Its Impact on Tuberculosis Treatment in South Asia: A Systematic Review and Meta-Analysis. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-81057-2"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Nowi\u0144ski, A., Weso\u0142owski, S., and Korzeniewska-Kose\u0142a, M. (2023). The Impact of Comorbidities on Tuberculosis Treatment Outcomes in Poland: A National Cohort Study. Front. Public Health, 11.","DOI":"10.3389\/fpubh.2023.1253615"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Cioboata, R., Vasile, C.M., B\u0103lteanu, M.A., Georgescu, D.E., Toma, C., Dracea, A.S., and Nicolosu, D. (2024). Evaluating Serum Calcium and Magnesium Levels as Predictive Biomarkers for Tuberculosis and COVID-19 Severity: A Romanian Prospective Study. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25010418"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5588\/ijtld.18.0359","article-title":"Point of care HbA1c level for diabetes mellitus management and its accuracy among tuberculosis patients: A study in four countries","volume":"23","author":"Huangfu","year":"2019","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Koo, H.K., Min, J., Kim, H.W., Lee, J., Kim, J.S., Park, J.S., and Lee, S.S. (2020). Prediction of Treatment Failure and Compliance in Patients with Tuberculosis. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-020-05350-7"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Kenya, Uganda, Zambia, and Zimbabwe TB Disability Study Group, Adakun, S.A., Banda, F.M., Bloom, A., Bochnowicz, M., Chakaya, J., Chansa, A., Chiguvare, H., Chimzizi, R., and Colvin, C. (2024). Disability, Comorbidities and Risk Determinants at End of TB Treatment in Kenya, Uganda, Zambia and Zimbabwe. IJTLD Open, 1, 197\u2013205.","DOI":"10.5588\/ijtldopen.24.0082"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"agad073","DOI":"10.1093\/alcalc\/agad073","article-title":"A Retrospective Cohort Analysis of Treatment Outcomes of Patients with Tuberculosis Who Used Substances in Tel Aviv, Israel","volume":"59","author":"Kaliner","year":"2024","journal-title":"Alcohol. Alcohol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Yerezhepov, D., Gabdulkayum, A., Akhmetova, A., Kozhamkulov, U., Rakhimova, S., Kairov, U., Zhunussova, G., Kalendar, R., and Akilzhanova, A. (2024). Pulmonary Tuberculosis Epidemiology and Genetics in Kazakhstan. Front. Public Health, 12.","DOI":"10.3389\/fpubh.2024.1340673"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-P\u00e9rez, H.J., Gordillo-Marroqu\u00edn, C., V\u00e1zquez-Marcel\u00edn, J., Mart\u00edn-Mateo, M., and G\u00f3mez-Velasco, A. (2024). Sociodemographic Factors Associated with the Success or Failure of Antituberculosis Treatment in the Chiapas Highlands, Mexico, 2019\u20132022. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0296924"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5812\/ijhrba.5215","article-title":"Association between Tuberculosis and Smoking","volume":"1","author":"Metanat","year":"2012","journal-title":"Int. J. High Risk Behav. Addict."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/resp.12515","article-title":"Epidemiologic Link between Tuberculosis and Cigarette\/Biomass Smoke Exposure: Limitations Despite the Vast Literature","volume":"20","author":"Bishwakarma","year":"2015","journal-title":"Respirology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/jech-2014-204292","article-title":"Cigarette Smoking and Pulmonary Tuberculosis in Northern California","volume":"69","author":"Smith","year":"2015","journal-title":"J. Epidemiol. Community Health"},{"key":"ref_30","first-page":"2970","article-title":"Smoking Cessation among Tuberculosis Patients during the Coronavirus Disease-2019 Pandemic. Monaldi Arch","volume":"95","author":"Coutinho","year":"2024","journal-title":"Chest Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1602308","DOI":"10.1183\/13993003.02308-2016","article-title":"World Health Organization Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update","volume":"49","author":"Falzon","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1183\/09031936.00193413","article-title":"Financial Burden for Tuberculosis Patients in Low- and Middle-Income Countries: A Systematic Review","volume":"43","author":"Tanimura","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_33","unstructured":"World Health Organization (2010). Treatment of Tuberculosis: Guidelines, WHO. [4th ed.]."},{"key":"ref_34","unstructured":"World Health Organization (2022). Rapid Communication: Key Changes to the Treatment of Drug-Susceptible Tuberculosis, WHO."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1901814","article-title":"Treatment of Highly Drug-Resistant Pulmonary Tuberculosis","volume":"382","author":"Conradie","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_36","unstructured":"Government of the Republic of Lithuania (2012). Resolution No. 1482 of 28 November 2012 on the Approval of the National Progress Programme for 2014\u20132020, Government of the Republic of Lithuania. Document No. 142-7294."},{"key":"ref_37","unstructured":"Minister of Health of the Republic of Lithuania (2025, July 17). Order No. V-815 of 16 July 2014 on the Approval of the Action Plan for Reducing Health Inequalities in Lithuania for 2014\u20132023. Available online: https:\/\/e-seimas.lrs.lt\/portal\/legalAct\/lt\/TAD\/40be0b700df611e48595a3375cdcc8a3\/vnzrzALKZv."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e20220137","DOI":"10.1590\/1980-220x-reeusp-2022-0137en","article-title":"Tuberculosis from the perspective of men and women","volume":"56","author":"Pinto","year":"2022","journal-title":"Rev. Esc. Enferm. USP"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Peer, V., Schwartz, N., and Green, M.S. (2022). Gender differences in tuberculosis incidence rates\u2014A pooled analysis of data from seven high-income countries by age group and time period. Front. Public Health, 10.","DOI":"10.3389\/fpubh.2022.997025"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e588","DOI":"10.1016\/S2468-2667(25)00120-3","article-title":"Sex differences in the risk of Mycobacterium tuberculosis infection: A systematic review and meta-analysis of population-based immunoreactivity surveys","volume":"10","author":"Rickman","year":"2025","journal-title":"Lancet Public Health"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/10\/1805\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:50:44Z","timestamp":1760035844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/10\/1805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":40,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["medicina61101805"],"URL":"https:\/\/doi.org\/10.3390\/medicina61101805","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]}}}